cardiovascular system
• moderate increase in heart weight
|
liver/biliary system
• reduction in liver weight (27% less than wild-type)
|
hematopoietic system
• moderate increase in spleen weight
|
homeostasis/metabolism
• resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced toxicity; mutants do not exhibit hepatomegaly, thymic involution or cleft palate formation in response to TCDD administration as seen in controls
|
immune system
• moderate increase in spleen weight
|
cellular
growth/size/body
• moderate increase in heart weight
|
• moderate increase in spleen weight
|